Blink Health, a NYC-based tech platform for consumers to acquire medications at discounted proce across over 57,000 pharmacies nationwide, raised a $90m Series B funding.
The round, which brought total financing raised by the company to date to $165m, was led by 8VC.
The company intends to use the funds to accelerate expansion in the USA.
Founded in 2014 by CEO Geoffrey Chaiken and COO Matthew Chaiken, Blink Health provides a free mobile app and website that allow users to purchase their medications online and pick them up at their local retailer at a discounted price (up to 90% off the average retail price). To this end, the company groups patients together to leverage their purchasing power and secure lower prices for the most-prescribed medications in America.
Blink, which now has over one million monthly active users, has also announced multiple branded drug programs, including an insulin discount program with pharmaceutical company Eli Lilly.